31
TITLE: Concentration‐Dependent Clinical and Prognostic Importance of High‐Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR‐Reduced Trial
AUTHORS: Milton Packer; James L Januzzi; Joao Pedro Ferreira ; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Martina Brueckmann; Waheed Jamal; Daniel Cotton; Tomoko Iwata; Faiez Zannad;
PUBLISHED: 2021, SOURCE: European Journal of Heart Failure
INDEXED IN: CrossRef: 30
32
TITLE: New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial  Full Text
AUTHORS: João Pedro Ferreira ; John G Cleland; Carolyn S P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J van Veldhuisen; William M Byra; David A LaPolice; Barry Greenberg; Faiez Zannad;
PUBLISHED: 2021, SOURCE: Clinical Research in Cardiology
INDEXED IN: CrossRef: 5
33
TITLE: Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
AUTHORS: Carolyn S P Lam; João Pedro Ferreira ; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Naveed Sattar; Subodh Verma; Martina Brueckmann; Janet Schnee; Daniel Cotton; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: European Heart Journal
INDEXED IN: CrossRef: 39
34
TITLE: Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
AUTHORS: Pocock, Stuart J.; Ferreira, Joao Pedro ; Gregson, John; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Gollop, Nicholas D.; Iwata, Tomoko; Brueckmann, Martina; Januzzi, James L., Jr.; Voors, Adriaan A.; Zannad, Faiez; Packer, Milton;
PUBLISHED: 2021, SOURCE: EUROPEAN HEART JOURNAL, VOLUME: 42, ISSUE: 43
INDEXED IN: WOS CrossRef: 35
35
TITLE: Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial
AUTHORS: Packer, M; Zannad, F; Butler, J; Filippatos, G; Ferreira, JP ; Pocock, SJ; Brueckmann, M; Zeller, C; Hauske, S; Anker, SD;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 23, ISSUE: 10
INDEXED IN: WOS CrossRef: 24
36
TITLE: Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial  Full Text
AUTHORS: James L Januzzi; Faiez Zannad; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; João Pedro Ferreira ; Naveed Sattar; Subodh Verma; Ola Vedin; Janet Schnee; Tomoko Iwata; Dan Cotton; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
INDEXED IN: CrossRef: 68
37
TITLE: Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure  Full Text
AUTHORS: Michael Böhm; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Felix Mahfoud; Martina Brueckmann; Waheed Jamal; Anne Pernille Ofstad; Elke Schüler; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
INDEXED IN: CrossRef: 58
38
TITLE: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
AUTHORS: Pitt, B; Filippatos, G; Agarwal, R; Anker, SD; Bakris, GL; Rossing, P; Joseph, A; Kolkhof, P; Nowack, C; Schloemer, P; Ruilope, LM;
PUBLISHED: 2021, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 385, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef: 120 Unpaywall
39
TITLE: Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)  Full Text
AUTHORS: Seferovic, PM; Fragasso, G; Petrie, M; Mullens, W; Ferrari, R; Thum, T; Bauersachs, J; Anker, SD; Ray, R; Cavusoglu, Y; Polovina, M; Metra, M; Ambrosio, G; Prasad, K; Seferovic, J; Jhund, PS; Dattilo, G; Celutkiene, J; Piepoli, M; Moura, B ; Chioncel, O; Ben Gal, T; Heymans, S; Jaarsma, T; Hill, L; Lopatin, Y; Lyon, AR; Ponikowski, P; Lainscak, M; Jankowska, E; Mueller, C; Cosentino, F; Lund, LH; Filippatos, GS; Ruschitzka, F; Coats, AJS; Rosano, GMC; ...More
PUBLISHED: 2020, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 22, ISSUE: 11
INDEXED IN: Scopus WOS
40
TITLE: Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial
AUTHORS: João Pedro Ferreira ; Carolyn S.P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J Veldhuisen; William M Byra; David A La Police; John G.F Cleland; Barry Greenberg; Faiez Zannad;
PUBLISHED: 2020, SOURCE: European Journal of Heart Failure, VOLUME: 23, ISSUE: 4
INDEXED IN: CrossRef: 13
Page 4 of 6. Total results: 52.